Medicare AdvantageJune 1, 2021
Medical policies and clinical utilization management guidelines update
The Medical Policies, Clinical Utilization Management (UM) Guidelines and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed. Please note: The Medical Policies and Clinical UM Guidelines below are followed in the absence of Medicare guidance.
Please share this notice with other members of your practice and office staff.
To view a guideline, visit https://www.anthem.com/provider/news/archives/?category=medicareadvantage.
Notes/updates:
Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
- *CG-LAB-17 - Molecular Gastrointestinal Pathogen Panel (GIPP) Testing for Infectious Diarrhea in the Outpatient Setting
- Outlines the medical necessity and not medically necessary criteria for multiplex PCR-based panel testing of gastrointestinal pathogens for infectious diarrhea in the outpatient setting
- *ANC.00008 - Cosmetic and Reconstructive Services of the Head and Neck
- Added otoplasty using a custom-fabricated device, including but not limited to a custom fabricated alloplastic implant, as cosmetic and not medically necessary
- *CG-OR-PR-04 - Cranial Remodeling Bands and Helmets (Cranial Orthotics)
- Removed condition requirement from reconstructive criteria and replaced current diagnostic reconstructive criteria with criteria based on one of the following cephalometric measurements: the cephalic index, the cephalic vault asymmetry index, the oblique diameter difference index, or the cranioproportional index of plagiocephelometry
- *CG-SURG-78 - Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies
- Added TACE using immunoembolization (for example, using granulocyte-macrophage colony-stimulating factor [GM-CSF]) as not medically necessary for all liver-related indications
- *CG-SURG-82 - Bone-Anchored and Bone Conduction Hearing Aids
- Revised audiologic pure tone average bone conduction threshold criteria for unilateral implant for bilateral hearing loss
- Added not medically necessary statement for when medical necessity criteria have not been met and clarified not medically necessary statement regarding replacement parts or upgrades
- Added bone conduction hearing aids using an adhesive adapter behind the ear as not medically necessary for all indications
- CG-GENE-22 - Gene Expression Profiling for Managing Breast Cancer Treatment
- A new Clinical Guideline was created from the content contained in GENE.00011. There are no changes to the guideline content and the publish date is April 7, 2021.
- CG-GENE-23 - Genetic Testing for Heritable Cardiac Conditions
- A new Clinical Guideline was created from the content contained in GENE.00007 and GENE.00017. There are no changes to the guideline content and the publish date is April 7, 2021
- CG-SURG-110 - Lung Volume Reduction Surgery
- A new Clinical Guideline was created from the content contained in SURG.00022. There are no changes to the guideline content and the publish date is June 25, 2021
AIM Specialty Health®* Clinical Appropriateness Guideline updates. To view AIM guidelines, visit the AIM Specialty Health page.
- The Small Joint Surgery Guideline has been revised and will be effective on March 14, 2021.
- The following guidelines have been revised and will be effective on June 4, 2021.
- * Imaging of the Spine
- * Imaging of the Extremities
- * Vascular Imaging
- * Joint Surgery
- * Spine Surgery
Medical Policies
On February 11, 2021, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem Blue Cross (Anthem). These guidelines take effect June 4, 2021.
Publish date |
Medical Policy number |
Medical Policy title |
New or revised |
4/7/2021 |
*ANC.00008 |
Cosmetic and Reconstructive Services of the Head and Neck |
Revised |
2/18/2021 |
SURG.00121 |
Transcatheter Heart Valve Procedures |
Revised |
2/18/2021 |
SURG.00145 |
Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts) |
Revised |
Clinical UM Guidelines
On February 11, 2021, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Anthem members on February 25, 2021. These guidelines take effect June 4, 2021.
Publish date |
Clinical UM Guideline number |
Clinical UM Guideline title |
New or revised |
4/7/2021 |
*CG-LAB-17 |
Molecular Gastrointestinal Pathogen Panel (GIPP) Testing for Infectious Diarrhea in the Outpatient Setting |
New |
2/18/2021 |
CG-GENE-21 |
Cell-Free Fetal DNA-Based Prenatal Testing |
Revised |
4/7/2021 |
CG-MED-26 |
Neonatal Levels of Care |
Revised |
2/18/2021 |
CG-MED-87 |
Single Photon Emission Computed Tomography Scans for Noncardiovascular Indications |
Revised |
4/7/2021 |
*CG-OR-PR-04 |
Cranial Remodeling Bands and Helmets (Cranial Orthotics) |
Revised |
2/18/2021 |
CG-SURG-55 |
Intracardiac Electrophysiological Studies (EPS) and Catheter Ablation |
Revised |
4/7/2021 |
CG-SURG-71 |
Reduction Mammaplasty |
Revised |
4/7/2021 |
*CG-SURG-78 |
Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies |
Revised |
4/7/2021 |
*CG-SURG-82 |
Bone-Anchored and Bone Conduction Hearing Aids |
Revised |
4/7/2021 |
CG-SURG-97 |
Cardioverter Defibrillators |
Revised |
518566MUPENMUB
PUBLICATIONS: June 2021 Anthem Blue Cross Provider News - California
To view this article online:
Or scan this QR code with your phone